Compile Data Set for Download or QSAR
Report error Found 97 Enz. Inhib. hit(s) with all data for entry = 9806
TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489718(US10968163, Compound 3l-D)
Affinity DataKi:  10nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489713(US10968163, Compound 3k)
Affinity DataKi:  20nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489717(US10968163, Compound 3l-C)
Affinity DataKi:  20nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489714(US10968163, Compound 3l)
Affinity DataKi:  20nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468474(CHEMBL4293553 | US10968163, Compound 3d)
Affinity DataKi:  30nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468463(CHEMBL4290535 | US10968163, Compound 3i)
Affinity DataKi:  30nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489733(US10968163, Compound 4e)
Affinity DataKi:  30nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489716(US10968163, Compound 3l-B)
Affinity DataKi:  30nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468465(CHEMBL4288603 | US10968163, Compound 3l-A)
Affinity DataKi:  30nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489714(US10968163, Compound 3l)
Affinity DataKi:  30nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468443(CHEMBL4287414 | US10968163, Compound 4b | US202303...)
Affinity DataKi:  40nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468446(CHEMBL4292323 | US10968163, Compound 4k)
Affinity DataKi:  50nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468443(CHEMBL4287414 | US10968163, Compound 4b | US202303...)
Affinity DataKi:  50nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489733(US10968163, Compound 4e)
Affinity DataKi:  60nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468458(CHEMBL4285313 | US10968163, Compound 3b)
Affinity DataKi:  60nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468468(CHEMBL4282121 | US10968163, Compound 3t)
Affinity DataKi:  70nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  70nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM489733(US10968163, Compound 4e)
Affinity DataKi:  80nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468462(CHEMBL4287117 | US10968163, Compound 3g | US202303...)
Affinity DataKi:  80nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468472(CHEMBL4281708 | US10968163, Compound 3m)
Affinity DataKi:  90nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  90nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM489700(US10968163, Compound 3-B)
Affinity DataKi:  100nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM50468452(CHEMBL4283759 | US10968163, Compound 3e)
Affinity DataKi:  100nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468458(CHEMBL4285313 | US10968163, Compound 3b)
Affinity DataKi:  100nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489713(US10968163, Compound 3k)
Affinity DataKi:  110nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489726(US10968163, Compound 3s)
Affinity DataKi:  110nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468462(CHEMBL4287117 | US10968163, Compound 3g | US202303...)
Affinity DataKi:  120nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468478(CHEMBL4280183 | US10968163, Compound 4j | US202303...)
Affinity DataKi:  120nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489701(US10968163, Compound 3a)
Affinity DataKi:  120nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489706(US10968163, Compound 3f)
Affinity DataKi:  120nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489700(US10968163, Compound 3-B)
Affinity DataKi:  140nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489698(US10968163, Compound 3-A | US10968163, Compound 3)
Affinity DataKi:  140nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489706(US10968163, Compound 3f)
Affinity DataKi:  150nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468472(CHEMBL4281708 | US10968163, Compound 3m)
Affinity DataKi:  150nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489737(US10968163, Compound 4h)
Affinity DataKi:  160nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM489700(US10968163, Compound 3-B)
Affinity DataKi:  160nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468474(CHEMBL4293553 | US10968163, Compound 3d)
Affinity DataKi:  160nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM50468463(CHEMBL4290535 | US10968163, Compound 3i)
Affinity DataKi:  160nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468467(CHEMBL4285544 | US10968163, Compound 3q)
Affinity DataKi:  160nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM50468443(CHEMBL4287414 | US10968163, Compound 4b | US202303...)
Affinity DataKi:  170nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468436(CHEMBL4295043 | US10968163, Compound 3h)
Affinity DataKi:  170nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468475(CHEMBL4279887 | US10968163, Compound 3j)
Affinity DataKi:  180nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM489736(US10968163, Compound 4g)
Affinity DataKi:  180nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468456(CHEMBL4278244 | US10968163, Compound 3o)
Affinity DataKi:  180nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM50468456(CHEMBL4278244 | US10968163, Compound 3o)
Affinity DataKi:  180nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468438(CHEMBL4282959 | US10968163, Compound 3c)
Affinity DataKi:  180nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468442(CHEMBL4276759 | US10968163, Compound 4a)
Affinity DataKi:  190nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, heart(Human)
The State University of New York

US Patent
LigandPNGBDBM50468442(CHEMBL4276759 | US10968163, Compound 4a)
Affinity DataKi:  190nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
The State University of New York

US Patent
LigandPNGBDBM50468452(CHEMBL4283759 | US10968163, Compound 3e)
Affinity DataKi:  210nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetFatty acid-binding protein, brain(Human)
The State University of New York

US Patent
LigandPNGBDBM50468438(CHEMBL4282959 | US10968163, Compound 3c)
Affinity DataKi:  210nMAssay Description:FABP5 was purified and delipidated as described previously (Kaczocha, M. et al. 2012). FABP5 (30 μg), NBD-stearate (1 μM), and a competitor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

Displayed 1 to 50 (of 97 total ) | Next | Last >>
Jump to: